Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

957

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

December 26, 2023

Study Completion Date

December 26, 2023

Conditions
Essential Hypertension
Interventions
DRUG

SPH3127 tablet

1 tablet

DRUG

SPH3127 tablet

2 tablets

DRUG

SPH3127 tablet

4 tablets

DRUG

Valsartan

1 valsartan capsule

DRUG

SPH3127 tablet

2 tablets

DRUG

Valsartan

1 valsartan capsule

Trial Locations (40)

100005

Beijing Hospital, Beijing

100069

Beijing Anzhen Hospital, Capital Medical University, Beijing

101299

Beijing Pinggu Hospital, Beijing

110022

Shengjing Hospital of China Medical University, Shenyang

110067

The People's Hospital of Liaoning Province, Shenyang

200025

Ruijin Hospital, Shanghai Jiaotong University School Of Medicine, Shanghai

210003

The Second Affiliated Hospital of Nanjing Medical University, Nanjin

210029

The First Affiliated Hospital with Nanjing Medical University, Nanjing

210031

Affiliated Hospital of Jiangsu University, Zhenjiang

215008

Suzhou Municipal Hospital, Suzhou

221004

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

221009

Xuzhou Central Hospital, Xuzhou

300122

People's Hospital of Tianjin, Tianjin

300142

Tianjin Fourth Central Hospital, Tianjin

310003

Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou

314408

Zhejiang Provincial people's Hospital, Hangzhou

404037

Affiliated Hospital of Chongqing Three Gorges Medical College, Chongqing

410008

The Third Xiangya Hospital of Central South University, Changsha

XiangYa Hospital CentralSouth University, Changsha

410012

The Second Xiangya Hospital of Central South University, Changsha

430022

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

430030

Tongji hospital,Tongji Medical college of HUST, Wuhan

463599

Henan Provincial People's Hospital, Zhengzhou

471002

Luoyang Third People's Hospital, Luoyang

510310

Guangdong Second Provincial General Hospital, Guangzhou

519041

Guangdong Provincial People's Hospital, Guangzhou

545026

Liuzhou people's Hospital, Liuzhou

571199

Hainan Third People's Hospital, Sanya

610044

West China Hospital,Sichuan University, Chengdu

730030

Lanzhou University Second Hospital, Lanzhou

750003

General Hospital of Ningxia Medical University, Yinchuan

The First People's Hospital of Yinchuan, Yinchuan

750306

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou

830011

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

061011

Cangzhou Central Hospital, Cangzhou

050030

The First Hospital of Hebei Medical University, Shijiazhuang

050051

The Third Hospital of Hebei Medical University, Shijiazhuang

024099

Chifeng Municipal Hospital, Chifeng

Unknown

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

044099

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY